• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection.

作者信息

Boucau Julie, Marino Caitlin, Regan James, Uddin Rockib, Choudhary Manish C, Flynn James P, Chen Geoffrey, Stuckwisch Ashley M, Mathews Josh, Liew May Y, Singh Arshdeep, Lipiner Taryn, Kittilson Autumn, Melberg Meghan, Li Yijia, Gilbert Rebecca F, Reynolds Zahra, Iyer Surabhi L, Chamberlin Grace C, Vyas Tammy D, Goldberg Marcia B, Vyas Jatin M, Li Jonathan Z, Lemieux Jacob E, Siedner Mark J, Barczak Amy K

机构信息

Ragon Institute, Cambridge, MA.

Brigham and Women's Hospital, Boston, MA.

出版信息

N Engl J Med. 2022 Jul 21;387(3):275-277. doi: 10.1056/NEJMc2202092. Epub 2022 Jun 29.

DOI:10.1056/NEJMc2202092
PMID:35767428
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9258747/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/216a/9258747/b3601a69c159/NEJMc2202092_f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/216a/9258747/b3601a69c159/NEJMc2202092_f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/216a/9258747/b3601a69c159/NEJMc2202092_f1.jpg

相似文献

1
Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection.新型冠状病毒奥密克戎（BA.1）感染中可培养病毒的脱落持续时间。
N Engl J Med. 2022 Jul 21;387(3):275-277. doi: 10.1056/NEJMc2202092. Epub 2022 Jun 29.
2
Prolonged presence of replication-competent SARS-CoV-2 in mildly symptomatic individuals: A report of two cases.在症状轻微的个体中持续存在有复制能力的 SARS-CoV-2：两例病例报告。
J Med Virol. 2021 Sep;93(9):5603-5607. doi: 10.1002/jmv.27021. Epub 2021 Apr 23.
3
Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein.人 Basigin（CD147）与 SARS-CoV-2 刺突糖蛋白不直接相互作用。
mSphere. 2021 Aug 25;6(4):e0064721. doi: 10.1128/mSphere.00647-21. Epub 2021 Aug 11.
4
Doxycycline Inhibition of a Pseudotyped Virus Transduction Does Not Translate to Inhibition of SARS-CoV-2 Infectivity.强力霉素抑制假型病毒转导并不意味着能抑制 SARS-CoV-2 感染性。
Viruses. 2021 Sep 1;13(9):1745. doi: 10.3390/v13091745.
5
Rapid COVID-19 Molecular Diagnostic System Using Virus Enrichment Platform.采用病毒富集平台的快速新冠病毒分子诊断系统
Biosensors (Basel). 2021 Oct 6;11(10):373. doi: 10.3390/bios11100373.
6
[Analysis of SARS-CoV-2 in the air of an ICU dedicated to covid-19 patients].[对收治新冠肺炎患者的重症监护病房空气中的严重急性呼吸综合征冠状病毒2的分析]
Med Intensiva (Engl Ed). 2021 May;45(4):247-250. doi: 10.1016/j.medin.2020.09.004. Epub 2020 Oct 10.
7
Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant.新冠病毒德尔塔变异株引发的大型溯源清晰的暴发中的病毒感染和传播。
Nat Commun. 2022 Jan 24;13(1):460. doi: 10.1038/s41467-022-28089-y.
8
A Recombinant Fragment of Human Surfactant Protein D Binds Spike Protein and Inhibits Infectivity and Replication of SARS-CoV-2 in Clinical Samples.人表面活性蛋白D的重组片段与刺突蛋白结合并抑制临床样本中SARS-CoV-2的感染性和复制。
Am J Respir Cell Mol Biol. 2021 Jul;65(1):41-53. doi: 10.1165/rcmb.2021-0005OC.
9
Detection of SARS-CoV-2 in conjunctival secretions from patients without ocular symptoms.从无眼部症状患者的结膜分泌物中检测到 SARS-CoV-2。
Infection. 2021 Apr;49(2):257-265. doi: 10.1007/s15010-020-01524-2. Epub 2020 Sep 17.
10
An intra-cytoplasmic route for SARS-CoV-2 transmission unveiled by Helium-ion microscopy.氦离子显微镜揭示的 SARS-CoV-2 胞内传播途径。
Sci Rep. 2022 Mar 8;12(1):3794. doi: 10.1038/s41598-022-07867-0.

引用本文的文献

1
Occupational exposure monitoring of airborne respiratory viruses in outpatient medical clinics.门诊医疗诊所空气中呼吸道病毒的职业暴露监测。
Aerosol Sci Technol. 2024 Oct 23. doi: 10.1080/02786826.2024.2403580.
2
Decoding the transcriptome from bulk RNA of infection-naïve versus imprinted patients with SARS-CoV-2 Omicron B.1.1.529.对未感染过与感染过严重急性呼吸综合征冠状病毒2奥密克戎B.1.1.529的患者的批量RNA转录组进行解码。
Microbiol Spectr. 2025 Jul 9:e0291424. doi: 10.1128/spectrum.02914-24.
3
Evaluating trade-offs between COVID-19 prevention and learning loss: an agent-based simulation analysis.
评估新冠疫情预防与学习损失之间的权衡：基于主体的模拟分析
R Soc Open Sci. 2025 Apr 23;12(4):231842. doi: 10.1098/rsos.231842. eCollection 2025 Apr.
4
Contact patterns between index patients and their close contacts and assessing risk for COVID-19 transmission during different exposure time windows: a large retrospective observational study of 450 770 close contacts in Shanghai.新冠病毒确诊患者与其密切接触者之间的接触模式以及评估不同暴露时间窗内新冠病毒传播风险：一项对上海450770名密切接触者的大型回顾性观察研究
BMJ Public Health. 2024 Apr 16;2(1):e000154. doi: 10.1136/bmjph-2023-000154. eCollection 2024 Jun.
5
Risk period for transmission of SARS-CoV-2 and seasonal influenza: a rapid review.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）和季节性流感传播的风险期：快速综述
Infect Control Hosp Epidemiol. 2025 Feb 24;46(3):1-9. doi: 10.1017/ice.2025.11.
6
Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance.模型表明，奈玛特韦-利托那韦治疗后SARS-CoV-2的反弹是由靶细胞保留以及病毒清除不完全共同驱动的。
J Virol. 2025 Mar 18;99(3):e0162324. doi: 10.1128/jvi.01623-24. Epub 2025 Feb 4.
7
A tight fit of the SIR dynamic epidemic model to daily cases of COVID-19 reported during the 2021-2022 Omicron surge in New York City: A novel approach.将 SIR 动态传染病模型与 2021-2022 年在纽约市奥密克戎疫情期间报告的每日 COVID-19 病例进行紧密拟合：一种新方法。
Stat Methods Med Res. 2024 Oct;33(10):1877-1898. doi: 10.1177/09622802241277956.
8
Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance.模型显示，奈玛特韦-利托那韦治疗后SARS-CoV-2反弹是由靶细胞保留以及病毒清除不完全共同驱动的。
bioRxiv. 2024 Sep 16:2024.09.13.613000. doi: 10.1101/2024.09.13.613000.
9
Genome-wide association study between SARS-CoV-2 single nucleotide polymorphisms and virus copies during infections.全基因组关联研究 SARS-CoV-2 单核苷酸多态性与感染期间病毒载量的关系。
PLoS Comput Biol. 2024 Sep 17;20(9):e1012469. doi: 10.1371/journal.pcbi.1012469. eCollection 2024 Sep.
10
Does the COVID-19 Vaccination Reduce the Risk to Transmit SARS-CoV-2 to Others?新冠病毒疫苗接种是否降低了将 SARS-CoV-2 传播给他人的风险？
Adv Exp Med Biol. 2024;1457:247-264. doi: 10.1007/978-3-031-61939-7_14.